Compare XPO & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XPO | LH |
|---|---|---|
| Founded | 2000 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Transportation Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3B | 21.7B |
| IPO Year | 2002 | 2005 |
| Metric | XPO | LH |
|---|---|---|
| Price | $202.90 | $253.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 9 |
| Target Price | $185.29 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 1.2M | 679.8K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.12% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | 0.85 | ★ 3.35 |
| Revenue | $7,744,000,000.00 | ★ $13,951,700,000.00 |
| Revenue This Year | $5.79 | $8.26 |
| Revenue Next Year | $6.39 | $4.81 |
| P/E Ratio | $243.60 | ★ $76.79 |
| Revenue Growth | 0.34 | ★ 7.25 |
| 52 Week Low | $110.78 | $239.75 |
| 52 Week High | $231.46 | $293.72 |
| Indicator | XPO | LH |
|---|---|---|
| Relative Strength Index (RSI) | 43.87 | 37.41 |
| Support Level | $196.72 | $246.08 |
| Resistance Level | $207.04 | $275.06 |
| Average True Range (ATR) | 8.19 | 7.53 |
| MACD | -2.84 | -0.67 |
| Stochastic Oscillator | 11.59 | 17.26 |
Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. We estimate LTL shipping makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.